Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients

Detalles Bibliográficos
Autores principales: Aghamohammadi, Mehdi, Alizargar, Javad, Hsieh, Nan-Chen, Wu, Shu-Fang Vivienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Formosan Medical Association. Published by Elsevier Taiwan LLC. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211643/
https://www.ncbi.nlm.nih.gov/pubmed/32402522
http://dx.doi.org/10.1016/j.jfma.2020.05.005
_version_ 1783531484042231808
author Aghamohammadi, Mehdi
Alizargar, Javad
Hsieh, Nan-Chen
Wu, Shu-Fang Vivienne
author_facet Aghamohammadi, Mehdi
Alizargar, Javad
Hsieh, Nan-Chen
Wu, Shu-Fang Vivienne
author_sort Aghamohammadi, Mehdi
collection PubMed
description
format Online
Article
Text
id pubmed-7211643
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Formosan Medical Association. Published by Elsevier Taiwan LLC.
record_format MEDLINE/PubMed
spelling pubmed-72116432020-05-11 Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients Aghamohammadi, Mehdi Alizargar, Javad Hsieh, Nan-Chen Wu, Shu-Fang Vivienne J Formos Med Assoc Correspondence Formosan Medical Association. Published by Elsevier Taiwan LLC. 2020-07 2020-05-11 /pmc/articles/PMC7211643/ /pubmed/32402522 http://dx.doi.org/10.1016/j.jfma.2020.05.005 Text en © 2020 Formosan Medical Association. Published by Elsevier Taiwan LLC. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Aghamohammadi, Mehdi
Alizargar, Javad
Hsieh, Nan-Chen
Wu, Shu-Fang Vivienne
Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title_full Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title_fullStr Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title_full_unstemmed Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title_short Prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in COVID-19 patients
title_sort prophylactic anticoagulant therapy for reducing the risk of stroke and other thrombotic events in covid-19 patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211643/
https://www.ncbi.nlm.nih.gov/pubmed/32402522
http://dx.doi.org/10.1016/j.jfma.2020.05.005
work_keys_str_mv AT aghamohammadimehdi prophylacticanticoagulanttherapyforreducingtheriskofstrokeandotherthromboticeventsincovid19patients
AT alizargarjavad prophylacticanticoagulanttherapyforreducingtheriskofstrokeandotherthromboticeventsincovid19patients
AT hsiehnanchen prophylacticanticoagulanttherapyforreducingtheriskofstrokeandotherthromboticeventsincovid19patients
AT wushufangvivienne prophylacticanticoagulanttherapyforreducingtheriskofstrokeandotherthromboticeventsincovid19patients

Ejemplares similares